FDA approves AstraZeneca's non-small cell lung cancer treatment

[cafead]

via The U.S. Food and Drug Administration approved AstraZeneca's (AZN.L) blockbuster cancer drug, Imfinzi, for the treatment of patients with a type of non-small cell lung cancer on Thursday.

article source